CEO of Front Range Bio-sciences Reacts To First Public FDA Hearing On Sale of CBD

The FDA held its first public hearing on the sale of CBD today, as the trend continues to sweep the nation. Our very own Chloe Aiello spoke to Jon Vaught, CEO and Co-Founder of Front Range Biosciences about whether his opinions were changed from what was said in the hearing.
We use cookies and similar technologies on this site to collect identifiers, such as IP address, and cookie and device IDs as described in our Privacy Policy.